Medroxyprogesterone Acetate

CAS 71-58-9 12 current records 4 historicalSmall Molecule

Who holds supplier records for Medroxyprogesterone Acetate? 12 organisations hold a current record for Medroxyprogesterone Acetate: an active US FDA Type II Drug Master File or a CEP. A further 4 organisations have only historical (inactive) DMF filings. 8 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: China (5), Italy (2), Germany (1), Spain (1) and 1 other country (1); not recorded for 2.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Medroxyprogesterone Acetate: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/medroxyprogesterone-acetate

Reading the evidence

  • 12 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 5 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (12)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Medroxyprogesterone Acetate. Country is the organisation's recorded country, not necessarily the manufacturing site.

China5Italy2Germany1Spain1Netherlands1Country not recorded for 2
  • Bayer AG
    Active DMF 5389 · latest filing May 1984
    GermanyCEP Company GMP cert on record
  • CURIA SPAIN SAU
    Active DMF 28800 · latest filing Nov 2014
    SpainCEP Company GMP cert on record
  • Farmabios S.p.A.
    Active DMF 12695 · latest filing Oct 1997
    ItalyCEP Company GMP cert on record
  • TAPI NL BV
    Active DMF 12703 · latest filing Oct 1997
    NetherlandsCEP
  • ZHEJIANG XIANJU PHARMACEUTICAL CO LTD
    Active DMF 19433 · latest filing May 2006
    CEP
  • Amphastar Nanjing Pharmaceuticals
    Active DMF 32282 · latest filing Feb 2018
    China
  • Hubei Gedian Humanwell Pharmaceutical Co. Ltd
    Active DMF 27995 · latest filing Feb 2014
    China Company GMP cert on record
  • TAIZHOU TAIFA PHARMACEUTICALS CO LTD
    Active DMF 27546 · latest filing Oct 2014
  • ZHEJIANG XIANJU YANGGUANG BIOPRODUCTS CO LTD
    Active DMF 34977 · latest filing Jul 2020
    China
  • ChinaCEP
  • STERLING SPA
    Inactive DMF 15223 · latest filing Jan 2001
    ItalyCEP Company GMP cert on record
  • XIANJU SYNSEA BIOPHA CO. LTD.
    Valid CEP holder (EDQM); not necessarily the manufacturer
    ChinaCEP
Need Medroxyprogesterone Acetate sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (8)

Certificates of Suitability on the EDQM register for Medroxyprogesterone Acetate, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 13 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
ZHEJIANG XIANJU PHARMACEUTICAL CO., LTD. TaizhouCN
CEP 2025-317 - Rev 00
Medroxyprogesterone acetate, Non-micronised and micronised
Aug 2026—
XIANJU SYNSEA BIOPHA CO. LTD. TaizhouCN
CEP 2019-336 - Rev 01
Medroxyprogesterone acetate
Mar 2026—
FARMABIOS S.p.A Gropello CairoliIT
CEP 2023-423 - Rev 00
Medroxyprogesterone acetate, Micronised, Sterile
Mar 2025Inspected Jul 2026
Italy
TAPI NL B.V. AmsterdamNL
CEP 2000-276 - Rev 06
Medroxyprogesterone acetate, Micronised (M1, M2, M3)
Mar 2025—
CURIA SPAIN S.A.U. BoecilloES
CEP 2022-311 - Rev 00
Medroxyprogesterone acetate
Jan 2024Inspected Feb 2026
Spain
JIANGSU GRAND XIANLE PHARMACEUTICAL CO., LTD. YanchengCN
R1-CEP 2016-145 - Rev 00
Medroxyprogesterone acetate
Jun 2023—
BAYER AG LeverkusenDE
R1-CEP 1995-051 - Rev 07
Medroxyprogesterone acetate
Mar 2017—
STERLING S.p.A. Solomeo Di CorcianoIT
R1-CEP 2002-048 - Rev 01
Medroxyprogesterone acetate
Oct 2012—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (4)

Organisations whose Type II DMFs for Medroxyprogesterone Acetate are no longer active. These show a past filing, not current supply.

Show all 4 historical records
  • YANCHENG XINYI PHARM AND CHEM CO LTD
    Inactive DMF 21563 · filed Jan 2008
  • SOCIETA ITALIANA CORTICOSTEROIDI SPA
    Inactive DMF 6488 · filed Jul 1986
  • South Africa · Inactive DMF 5486 · filed Jul 1984
  • Brazil · Inactive DMF 2724 · filed Aug 1976

Overview

Medroxyprogesterone acetate is a synthetic progestin, a derivative of progesterone, used primarily for hormonal contraceptives and hormone replacement therapy. It is also used in the treatment of certain hormone-responsive cancers due to its ability to inhibit gonadotropin secretion.

Chemical identity

IUPAC name
[(6S,8R,9S,10R,13S,14S,17R)-17-acetyl-6,10,13-trimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate
Canonical SMILES
C[C@H]1C[C@@H]2[C@H](CC[C@]3([C@H]2CC[C@@]3(C(=O)C)OC(=O)C)C)[C@@]4(C1=CC(=O)CC4)C
InChIKey
PSGAAPLEWMOORI-PEINSRQWSA-N
Synonyms
Provera API; Depo-Provera API, amen, curretab, cycrin, depo-provera, depo-subq provera 104, depot-medroxyprogesterone acetate, dmpa, medroxyprogesterone 17-acetate, medroxyprogesteroni acetas, megestrol acetate impurity a, nsc-21171

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Progestin
Chemical structure
Progesterone Congeners

Therapeutic areas

Reproductive HealthHormonal TherapyOncology

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Medroxyprogesterone Acetate?

12 organisations hold an active US FDA Type II Drug Master File or a CEP for Medroxyprogesterone Acetate: Bayer AG (Germany), CURIA SPAIN SAU (Spain), Farmabios S.p.A. (Italy), TAPI NL BV (Netherlands), ZHEJIANG XIANJU PHARMACEUTICAL CO LTD, Amphastar Nanjing Pharmaceuticals (China), Hubei Gedian Humanwell Pharmaceutical Co. Ltd (China) and TAIZHOU TAIFA PHARMACEUTICALS CO LTD, and 4 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Medroxyprogesterone Acetate Drug Master Files are active?

Bayer AG (DMF 5389), CURIA SPAIN SAU (DMF 28800), Farmabios S.p.A. (DMF 12695), TAPI NL BV (DMF 12703), ZHEJIANG XIANJU PHARMACEUTICAL CO LTD (DMF 19433), Amphastar Nanjing Pharmaceuticals (DMF 32282), Hubei Gedian Humanwell Pharmaceutical Co. Ltd (DMF 27995) and TAIZHOU TAIFA PHARMACEUTICALS CO LTD (DMF 27546) and 1 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Medroxyprogesterone Acetate records mean?

4 organisations have only inactive Type II DMFs for Medroxyprogesterone Acetate. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Medroxyprogesterone Acetate have a European Certificate of Suitability?

Yes. 8 organisations hold a valid CEP for Medroxyprogesterone Acetate on the EDQM register, including ZHEJIANG XIANJU PHARMACEUTICAL CO., LTD. Taizhou (CN), XIANJU SYNSEA BIOPHA CO. LTD. Taizhou (CN), FARMABIOS S.p.A Gropello Cairoli (IT), TAPI NL B.V. Amsterdam (NL), CURIA SPAIN S.A.U. Boecillo (ES) and JIANGSU GRAND XIANLE PHARMACEUTICAL CO., LTD. Yancheng (CN) and 2 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Medroxyprogesterone Acetate supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Medroxyprogesterone Acetate?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.